Royal College of Nursing ends partnership with Israeli drugmaker Teva UK
The Royal College of Nursing in London has cut commercial ties with Teva UK over the company's links to Israel's military and its history of misconduct.
RCN removes sponsor from event
The union confirmed it will no longer accept sponsorship from Teva for an upcoming migraine and headache services summit scheduled for October 2026. This decision follows pressure from campaign groups who argued the partnership contradicts calls to isolate Israel through international sanctions.
Reasons for ending relationship
Leaders cited legal sanctions against specific Teva operations and public scrutiny of its business practices as primary factors. The union represents over 500,000 nurses across Britain who sought a clear stance on corporate entanglements with the Israeli military.
Event proceeds without sponsor
Carmel O'Boyle stated that the leadership summit will continue as planned despite the loss of this specific commercial partner. The move marks a significant shift after due diligence revealed further issues with the pharmaceutical giant's global operations.
All 2 outlets report consistently
No differences in figures, names or dates across these reports.
- The Guardian
- Middle East Eye
Reported by
2 independent outlets. Headlines as published. Links open the original report.